221 related articles for article (PubMed ID: 12439718)
1. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
Pedersen KB; Nesland JM; Fodstad Ø; Maelandsmo GM
Br J Cancer; 2002 Nov; 87(11):1281-6. PubMed ID: 12439718
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.
Kimura K; Endo Y; Yonemura Y; Heizmann CW; Schafer BW; Watanabe Y; Sasaki T
Int J Oncol; 2000 Jun; 16(6):1125-31. PubMed ID: 10811984
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
Zou W; Hu CH; Zhou JP
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
[TBL] [Abstract][Full Text] [Related]
6. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
7. Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma.
Andersen K; Nesland JM; Holm R; Flørenes VA; Fodstad Ø; Maelandsmo GM
Mod Pathol; 2004 Aug; 17(8):990-7. PubMed ID: 15133476
[TBL] [Abstract][Full Text] [Related]
8. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
10. Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma.
Yoon CS; Hyung WJ; Lee JH; Chae YS; Won NH; Yeom BW; Choi JS
Hepatogastroenterology; 2008; 55(86-87):1916-20. PubMed ID: 19102422
[TBL] [Abstract][Full Text] [Related]
11. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.
Oida Y; Yamazaki H; Tobita K; Mukai M; Ohtani Y; Miyazaki N; Abe Y; Imaizumi T; Makuuchi H; Ueyama Y; Nakamura M
Oncol Rep; 2006 Sep; 16(3):457-63. PubMed ID: 16865243
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
[TBL] [Abstract][Full Text] [Related]
17. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
[TBL] [Abstract][Full Text] [Related]
20. P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]